ECSP088958A - Moléculas duales que contienen un derivado peroxídico, - Google Patents
Moléculas duales que contienen un derivado peroxídico,Info
- Publication number
- ECSP088958A ECSP088958A EC2008008958A ECSP088958A ECSP088958A EC SP088958 A ECSP088958 A EC SP088958A EC 2008008958 A EC2008008958 A EC 2008008958A EC SP088958 A ECSP088958 A EC SP088958A EC SP088958 A ECSP088958 A EC SP088958A
- Authority
- EC
- Ecuador
- Prior art keywords
- represent
- optionally substituted
- cycloalkyl
- mixtures
- hydrogen atom
- Prior art date
Links
- 230000009977 dual effect Effects 0.000 title abstract 2
- 230000000078 anti-malarial effect Effects 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- -1 cyclic peroxide Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000000524 functional group Chemical group 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 125000003367 polycyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
- 125000006168 tricyclic group Chemical group 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La invención se refiere a las moléculas duales que responden a la fórmula (I): en la que: - A representa un resto de molécula con actividad antipalúdica de fórmulas (IIa) o (IIIa) o un resto que facilita la biodisponibilidad; - B representa un grupo cicloalquilo sustituido opcionalmente, o bien B representa un grupo bi o tricíclico que puede estar sustituido opcionalmente, o bien B representa 2 grupos cicloalquilo unidos entre sí por un enlace sencillo o una cadena alquileno; - m y n representan independientemente el uno del otro 0, 1 ó 2; - R5 representa un átomo de hidrógeno, un grupo alquilo, cicloalquilo o alquileno-C1-3-cicloalquilo; - Z1 y Z2, representan un radical alquileno, representando el conjunto Z1 + Z2 + Ci + Cj una estructura mono o policíclica, pudiendo representar uno de Z1 o Z2 un enlace sencillo; - R1 y R2, idénticos o diferentes, representan un átomo de hidrógeno o un grupo funcional capaz de incrementar la hidrosolubilidad; - Rx y Ry forman juntos un peróxido cíclico que consta de 4 a 8 eslabones y que consta de 1 ó 2 átomos de oxígeno adicionales en la estructura cíclica, sustituido opcionalmente con uno o varios grupos R3; en el estado de base o de sal de adición a un ácido, en el estado de hidrato o de solvato, en forma racémica, isómeros y sus mezclas, así como sus diastereoisómeros y sus mezclas. Procedimiento de preparación y aplicación como medicamentos con actividad antipalúdica.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0605235A FR2902100A1 (fr) | 2006-06-13 | 2006-06-13 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications en therapeutique |
| PCT/FR2007/000946 WO2007144487A2 (fr) | 2006-06-13 | 2007-06-08 | Molecules duales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP088958A true ECSP088958A (es) | 2009-01-30 |
Family
ID=37719816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2008008958A ECSP088958A (es) | 2006-06-13 | 2008-12-11 | Moléculas duales que contienen un derivado peroxídico, |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20120122923A1 (es) |
| EP (1) | EP2032561A2 (es) |
| JP (1) | JP2009539946A (es) |
| KR (1) | KR20090029208A (es) |
| CN (1) | CN101466706A (es) |
| AP (1) | AP2008004711A0 (es) |
| AR (1) | AR061347A1 (es) |
| AU (1) | AU2007259116A1 (es) |
| BR (1) | BRPI0713739A2 (es) |
| CA (1) | CA2665940A1 (es) |
| CR (1) | CR10469A (es) |
| EA (1) | EA200970002A1 (es) |
| EC (1) | ECSP088958A (es) |
| FR (1) | FR2902100A1 (es) |
| IL (1) | IL195394A0 (es) |
| MA (1) | MA30577B1 (es) |
| MX (1) | MX2008015980A (es) |
| NO (1) | NO20085308L (es) |
| PE (1) | PE20080335A1 (es) |
| TN (1) | TNSN08462A1 (es) |
| TW (1) | TW200817376A (es) |
| UY (1) | UY30413A1 (es) |
| WO (1) | WO2007144487A2 (es) |
| ZA (1) | ZA200810012B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2924343A1 (fr) * | 2007-12-04 | 2009-06-05 | Palumed Sa | Nouvelles utilisations therapeutiques de molecules duales contenant un derive peroxydique. |
| ES2609578T3 (es) | 2011-03-04 | 2017-04-21 | Glaxosmithkline Intellectual Property Development Limited | Amino-quinolinas como inhibidores de quinasa |
| TWI547494B (zh) | 2011-08-18 | 2016-09-01 | 葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之胺基喹唑啉類 |
| AR092529A1 (es) | 2012-09-13 | 2015-04-22 | Glaxosmithkline Llc | Compuesto de aminoquinazolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento |
| AR092530A1 (es) | 2012-09-13 | 2015-04-22 | Glaxosmithkline Llc | Compuesto de amino-quinolina, composicion farmaceutica que lo comprende y uso de dicho compuesto para la preparacion de un medicamento |
| CA2902132C (en) | 2013-02-21 | 2020-09-22 | Glaxosmithkline Intellectual Property Development Limited | Quinazolines as kinase inhibitors |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2133620A1 (en) * | 1993-10-28 | 1995-04-29 | Werner Hofheinz | Aminoquinoline derivatives |
| PT876346E (pt) * | 1995-11-16 | 2002-01-30 | Hoffmann La Roche | Derivados de quinolina com actividade anti-malaria |
| BR9909994A (pt) * | 1998-04-29 | 2000-12-26 | Smithkline Beecharm P L C | Quinolinas usadas como inibidores de mrs e bactericidas |
| FR2807433B1 (fr) * | 2000-04-06 | 2002-09-20 | Centre Nat Rech Scient | Molecules duales contenant un derives peroxydique, leur synthese et leurs applications therapeutiques |
| US6486199B1 (en) * | 2001-06-21 | 2002-11-26 | Medicines For Malaria Venture Mmv International Centre Cointrin | Spiro and dispiro 1,2,4-trioxolane antimalarials |
| WO2003070244A1 (en) * | 2002-02-22 | 2003-08-28 | Abbott Laboratories | Antagonist of melanin concentrating hormone and their uses |
| SE0202134D0 (sv) * | 2002-07-08 | 2002-07-08 | Astrazeneca Ab | Therapeutic agents |
| AU2003288899B2 (en) * | 2002-08-23 | 2009-09-03 | Novartis Vaccines And Diagnostics, Inc. | Benzimidazole quinolinones and uses thereof |
| US20050256157A1 (en) * | 2002-08-23 | 2005-11-17 | Chiron Corporation | Combination therapy with CHK1 inhibitors |
| EP1464335A3 (en) * | 2003-03-31 | 2007-05-09 | Taisho Pharmaceutical Co. Ltd. | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist |
| HU227684B1 (en) * | 2003-08-29 | 2011-11-28 | Sanofi Aventis | Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors |
| FR2862304A1 (fr) * | 2003-11-14 | 2005-05-20 | Centre Nat Rech Scient | Molecules duales racemiques ou achirales contenant un derive peroxydique, leur synthese et leurs applications therapeutiques |
| WO2005066132A1 (en) * | 2004-01-07 | 2005-07-21 | Astrazeneca Ab | Therapeutic agents i |
| AU2005283085B2 (en) * | 2004-06-18 | 2012-06-21 | 3M Innovative Properties Company | Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| FR2889525A1 (fr) * | 2005-08-04 | 2007-02-09 | Palumed Sa | Nouveaux derives de polyquinoleines et leur utilisation therapeutique. |
-
2006
- 2006-06-13 FR FR0605235A patent/FR2902100A1/fr not_active Withdrawn
-
2007
- 2007-06-08 JP JP2009514836A patent/JP2009539946A/ja not_active Withdrawn
- 2007-06-08 EP EP07788851A patent/EP2032561A2/fr not_active Withdrawn
- 2007-06-08 AP AP2008004711A patent/AP2008004711A0/xx unknown
- 2007-06-08 ZA ZA200810012A patent/ZA200810012B/xx unknown
- 2007-06-08 CN CNA2007800218550A patent/CN101466706A/zh active Pending
- 2007-06-08 AU AU2007259116A patent/AU2007259116A1/en not_active Abandoned
- 2007-06-08 CA CA002665940A patent/CA2665940A1/fr not_active Abandoned
- 2007-06-08 EA EA200970002A patent/EA200970002A1/ru unknown
- 2007-06-08 WO PCT/FR2007/000946 patent/WO2007144487A2/fr active Application Filing
- 2007-06-08 MX MX2008015980A patent/MX2008015980A/es active IP Right Grant
- 2007-06-08 BR BRPI0713739-7A patent/BRPI0713739A2/pt not_active IP Right Cessation
- 2007-06-08 KR KR1020087030376A patent/KR20090029208A/ko not_active Application Discontinuation
- 2007-06-12 PE PE2007000739A patent/PE20080335A1/es not_active Application Discontinuation
- 2007-06-12 AR ARP070102553A patent/AR061347A1/es not_active Application Discontinuation
- 2007-06-13 UY UY30413A patent/UY30413A1/es not_active Application Discontinuation
- 2007-06-13 TW TW096121347A patent/TW200817376A/zh unknown
-
2008
- 2008-11-17 TN TNP2008000462A patent/TNSN08462A1/en unknown
- 2008-11-19 IL IL195394A patent/IL195394A0/en unknown
- 2008-11-27 CR CR10469A patent/CR10469A/es not_active Application Discontinuation
- 2008-12-11 US US12/332,633 patent/US20120122923A1/en not_active Abandoned
- 2008-12-11 EC EC2008008958A patent/ECSP088958A/es unknown
- 2008-12-18 NO NO20085308A patent/NO20085308L/no not_active Application Discontinuation
-
2009
- 2009-01-06 MA MA31552A patent/MA30577B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2032561A2 (fr) | 2009-03-11 |
| CR10469A (es) | 2009-02-26 |
| PE20080335A1 (es) | 2008-05-22 |
| CA2665940A1 (fr) | 2007-12-21 |
| BRPI0713739A2 (pt) | 2013-06-18 |
| TW200817376A (en) | 2008-04-16 |
| JP2009539946A (ja) | 2009-11-19 |
| CN101466706A (zh) | 2009-06-24 |
| FR2902100A1 (fr) | 2007-12-14 |
| ZA200810012B (en) | 2010-05-26 |
| AR061347A1 (es) | 2008-08-20 |
| TNSN08462A1 (en) | 2010-04-14 |
| IL195394A0 (en) | 2009-08-03 |
| WO2007144487A2 (fr) | 2007-12-21 |
| AP2008004711A0 (en) | 2008-12-31 |
| WO2007144487A3 (fr) | 2008-02-07 |
| MA30577B1 (fr) | 2009-07-01 |
| US20120122923A1 (en) | 2012-05-17 |
| UY30413A1 (es) | 2008-01-31 |
| MX2008015980A (es) | 2009-03-26 |
| EA200970002A1 (ru) | 2009-06-30 |
| AU2007259116A8 (en) | 2009-04-30 |
| KR20090029208A (ko) | 2009-03-20 |
| NO20085308L (no) | 2009-03-12 |
| AU2007259116A1 (en) | 2007-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP088958A (es) | Moléculas duales que contienen un derivado peroxídico, | |
| UY30603A1 (es) | Derivados de 2-aril-6-fenil-imidazo[1, 2-a]piridinas, su preparacion y su aplicacion en terapéutica | |
| UY30130A1 (es) | Derivados de n-heteroaril-carboxamidas triciclicas que contienen un resto bencimidazol, su preparacion y su aplicacion en terapeutica. | |
| CR8756A (es) | Derivados de acido carboxilico bencimidazolona | |
| ES2525353T3 (es) | Derivado de espiroimidazolona | |
| AR044874A1 (es) | Derivados de 4- cianopirazol-3 - carboxamida, su preparacion y su aplicacion en terapeutica | |
| CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| GT200800258A (es) | Compuestos de pirrolo-pirimidina y sus usos | |
| ECSP088871A (es) | Derivados de triazolopirazina | |
| AR083070A1 (es) | Analogos de nucleotidos sustituidos con heterociclos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos para tratar enfermedades virales, en particular infecciones por vhc | |
| CR10027A (es) | Nuevos derivados de pirrol fusionado | |
| CY1109369T1 (el) | Υποκατεστημενες πυρρολοπυριδινες, οι ενωσεις που τις περιεχουν, η διαδικασια παρασκευης τους και η χρηση τους | |
| UY28955A1 (es) | Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
| CO6331462A2 (es) | Compuesto de fenil pirrol o una sal farmaceuticamente aceptable del mismo con actividad activadora de la glucoquinasa | |
| CO6210724A2 (es) | Compuesto heterociclico y composicion farmaceutica del mismo | |
| AR066972A1 (es) | Derivados azapeptidicos | |
| AR066103A1 (es) | Derivados de triazolopiridin - carboxamidas, su preparacion y su aplicacion en terapeutica | |
| AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
| CR9499A (es) | Nuevos derivados de fenilpiridinilpiperazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| AR079543A1 (es) | Derivados de amino-heteroarilo | |
| AR054128A1 (es) | Derivados del acido 6,7-dihidro-5h-imidazo(1, 2- a)imidazol-3-sulfonico | |
| EA200600761A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их |